The Future of Digital Therapeutics

Feb 21 · 3 minutes

What future do digital therapeutics have, and what potential can they offer in the near future?

The digitalization of wellness and health products has exploded in recent years. It provided new means that might allow tackling various health-related issues. Also, they help to find approachable alternatives to offer people a better chance to attain well-being.

But what future do the digital health platforms have, and what potential can they offer in the near future?

Let’s start with the basics

For starters, let’s begin by defining what digital health is.

Digital health is like an umbrella term that consists of several types of software platforms. It comprises devices, wearables and sensors, health data technology, personalized medicine, and digital therapeutics (DTx).

The most promising field of digital health is its subsection DTx. It contains multiple technologies and services that can aid healthcare and wellness industries.

DTx has a unique capability to commit clinically proven therapeutic interventions to prevent, manage, or treat medical disorders or diseases. Digital therapeutics provide an additional help alongside traditional treatment of health conditions. Also, it can be a replacement for conventional pharmaceuticals in general.

The future of DTx

In recent years, the DTx industry is growing fast and has the potential to replace some traditional therapeutics. For example, DTx-based mobile apps and devices can help patients manage their medical conditions. These apps remind them about dosage time, making medication adherence more comfortable. It can also guide users in reaching a healthy lifestyle, managing diseases like diabetes, or aiding those with chronic disorders like PTSD.

DTx progress and the ability to cover more health-related concerns have a lot to do with recent technological advancements. Nowadays, there’s a chance of producing these devices and software platforms at optimal speed and quantity, making DTx more cost-effective than ever.

Industrial Obstacles

Despite the growing DTx industry, it has versatile ability in providing solutions to health problems and data confirming their clinical value. It faces some struggles in taking part in the healthcare mainstream. This industrial obstacle stems from two reasons.

First of all, it’s pretty challenging for consumers and medical professionals to distinguish apps in terms of which one has or doesn’t have a proven therapeutic value. That’s why in some countries like the US and Germany, institutions became responsibile for overseeing the accreditation. They check DTx platforms for their clinical validity and mark these products so that each medical specialist could recognize them.

Developers who want to sell their software and receive accreditation have to carry out trials, collect data, and follow other procedures.

There is another obstacle to solved on the road to the wide adoption of digital therapeutics. It is the misalignment of incentives among providers, payers, and pharmaceutical companies.

Changing the workflows

DTx asks healthcare providers to change their workflows. That would mean that specialists would have to learn how to adopt digital tools within their medical practice. There is a high chance that the payer will expect some reimbursement before getting a DTx as well.

Yet, the healthcare bureaucratic processes would need administrative adjustment in order to find enough cash to ensure compensation.

In that regard, pharmaceutical and insurance companies will demand from DTx developers to prove their platform’s effectiveness. Companies will have to back their claims up with comprehensive data. This process might take some precious time. However, collecting needed information about products’ benefits won’t 100% guarantee that healthcare-related institutions approved the app.

No matter these struggles, there’s a positive aspect behind these industrial obstacles as well. The shared interest in DTx has brought both pharmaceutical companies and software developers in one place. This fascination has created new opportunities to share know-how from both sides, potentially accelerating the development and adoption of DTx.

The bottom line

That being said, digital therapeutics (DTx) will soon become a new category of medicine.

It is capable of addressing all kinds of health conditions and helping people in need. Much work remains for developers and specialists working in the healthcare system in finding the best way to integrate DTx within the traditional medical ecosystem. Yet, by keeping up with the current pace and determination, DTx can become an indispensable part of medical practice.

If you want to find out more about digital therapeutics, check out Kasparas Aleknavičius’ presentation at the “Health for all 2021” conference here.

Kasparas Aleknavicius
Head of Medical Affairs at Kilo Health
Medical doctor turned health futurist who finds joy in chess, jogging, and open-fire cooking.

Latest articles

Sculpting a Powerful Brand Identity With Content Designer Juste
Nov 25

Content Designer Juste Kulikauskaite is taking care of the verbal identity of Kilo Health brands. In essence, she shapes the way our products connect with our customers.  Today, I wanted to ask her more about her daily work – and…

Read more
Why the Himalayas Are Not High Enough for Mountaineer Dziugas Skrupskelis 
Nov 8
Kilo Heroes

Dziugas Skrupskelis has an inquisitive mind that can get him out of any situation – from climbing ice on a frozen waterfall to laying out a strategy that would help a struggling product flourish. He is the Chief Creative Officer…

Read more
Mental Health in the Workplace
Oct 24

Today, we are more than ever focused on the freedom of expressing our feelings, reflecting on them, working with our insecurities, and better understanding our mental health. Companies are also seeking to create a welcoming environment for their employees and…

Read more

Stay on top of health and wellness news

Kilo Outsider is a curated monthly newsletter for everyone who cares about health – from investors to policy makers, from entrepreneurs to healthy living enthusiasts.